| scholarly article | Q13442814 |
| P2093 | author name string | Sheraz Markar | |
| Karina Tukanova | |||
| Sara Jamel | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Smoking Exposure and Survival of Patients with Esophagus Cancer: A Systematic Review and Meta-Analysis | Q26748758 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer | Q33374495 | ||
| Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions | Q35054646 | ||
| Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent | Q36391839 | ||
| Metachronous pulmonary metastasis after radical esophagectomy for esophageal cancer: prognosis and outcome | Q36418207 | ||
| Palliative chemotherapy for recurrent and metastatic esophageal cancer | Q36908846 | ||
| Novel insights of oligometastases and oligo-recurrence and review of the literature | Q38042427 | ||
| Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial | Q38377462 | ||
| Surgical treatment for pulmonary metastases from esophageal carcinoma after definitive chemoradiotherapy: experience from a single institution | Q38867812 | ||
| The role of pulmonary resection in tumors metastatic from esophageal carcinoma | Q40570609 | ||
| Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. | Q40645806 | ||
| Pulmonary Resection for Metastatic Gastric Cancer | Q40780057 | ||
| Outcomes of aggressive treatment in esophageal cancer patients with synchronous solitary brain metastasis. | Q40992132 | ||
| Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection | Q43527927 | ||
| Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing | Q43672000 | ||
| Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial | Q44017893 | ||
| Disease-free interval length correlates to prognosis of patients who underwent metastasectomy for esophageal lung metastases | Q44229017 | ||
| Patterns and time of recurrence after complete resection of esophageal cancer | Q44346021 | ||
| Sites of metastasis and overall survival in esophageal cancer: a population-based study | Q47097386 | ||
| Patterns of distant organ metastases in esophageal cancer: a population-based study | Q47118283 | ||
| Predictors of Survival After Treatment of Oligometastases After Esophagectomy | Q47252476 | ||
| Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy | Q48603646 | ||
| Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection | Q48909742 | ||
| Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases | Q49186620 | ||
| Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. | Q51095826 | ||
| Prognostic factors for medium- and long-term survival of esophageal cancer patients in the Netherlands. | Q51142544 | ||
| Surgical outcomes of pulmonary metastases from esophageal carcinoma diagnosed by both pathological and clinical criteria. | Q53018992 | ||
| Operative treatment for metachronous pulmonary metastasis from esophageal carcinoma. | Q53073309 | ||
| Esophageal Cancer | Q56209683 | ||
| Oligometastases revisited | Q56773912 | ||
| Methodological quality and synthesis of case series and case reports | Q57269292 | ||
| Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution | Q57845858 | ||
| Associated primary esophageal and lung carcinoma: A study of 39 patients | Q71653842 | ||
| Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease | Q73169047 | ||
| Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer | Q73707393 | ||
| Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy | Q75401601 | ||
| Pulmonary resection for metastasis from esophageal carcinoma | Q81462192 | ||
| Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor | Q83274846 | ||
| Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma | Q85410076 | ||
| Pulmonary metastasectomy secondary to esophageal carcinoma: long-term survival and prognostic factors | Q87812187 | ||
| Liver metastases from esophageal carcinoma: is there a role for surgical resection? | Q88019295 | ||
| P433 | issue | 9 | |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 741-749 | |
| P577 | publication date | 2019-09-01 | |
| P1433 | published in | World journal of gastrointestinal oncology | Q27723329 |
| P1476 | title | Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: A systematic review | |
| P478 | volume | 11 |
Search more.